Dual-use technologies-innovations that serve both civilian and military purposes-are reshaping global regulatory landscapes. Advances in artificial intelligence (AI), biotechnology, and energy systems illustrate how breakthroughs designed for commercial or humanitarian use can simultaneously enhance defense capabilities. This convergence creates opportunities for innovation but also raises complex governance challenges.
- Civilian applications: predictive healthcare, autonomous vehicles, smart manufacturing, financial risk modeling.
- Military applications: autonomous weapons, battlefield surveillance, cyber defense, decision-support systems.
- Regulatory challenge: ensuring ethical deployment while preventing proliferation of AI-enabled weaponry. Export controls and algorithmic transparency are central concerns.
- Civilian applications: gene therapies, synthetic biology for agriculture, pandemic preparedness.
- Military applications: bio-enhanced soldier resilience, pathogen detection, potential misuse in bioweapons.
- Regulatory challenge: balancing innovation in life sciences with strict biosafety and biosecurity frameworks. Oversight must address dual-use research of concern (DURC).
- Civilian applications: renewable energy grids, battery storage, hydrogen fuel, nuclear medicine.
- Military applications: portable power for field operations, directed-energy weapons, nuclear propulsion.
- Regulatory challenge: managing proliferation risks (e.g., nuclear dual-use), while enabling sustainable energy transitions.
3. Regulatory and Governance Challenges
| Challenge | Civilian Impact | Military Risk | Regulatory Response |
| Export Controls | Limits global collaboration | Prevents adversarial acquisition | Harmonization under Wassenaar Arrangement, ITAR, EU Dual-Use Regulation |
| Research Oversight | Encourages innovation | Risk of weaponization | Institutional review boards, DURC policies |
| Intellectual Property | Incentivizes R&D | Risk of defense appropriation | Licensing frameworks with security carve-outs |
| International Norms | Facilitates cooperation | Risk of arms race | Geneva Conventions, Biological Weapons Convention, AI ethics guidelines |
4. Strategic Considerations for Stakeholders
- Governments: must balance national security with economic competitiveness.
- Industry: needs clear compliance pathways for export controls and licensing.
- Academia: should adopt responsible research practices and disclosure norms.
- Technology Transfer Offices (TTOs): must evaluate dual-use potential in licensing and spin-out decisions.
Dual-use technologies blur the line between civilian innovation and military capability. Effective governance requires multi-layered regulation, international cooperation, and responsible innovation frameworks. Stakeholders must anticipate dual-use risks early in the innovation cycle, embedding safeguards into contracts, licensing, and compliance systems.
Disclaimer: This note is provided for informational purposes only and does not constitute legal, regulatory, or compliance advice. Users should consult relevant experts and authorities before making decisions based on the content herein.